NATIONAL VACCINE INFORMATION CENTER
Balance Sheet
Fiscal Year Start:
Sep 1
Assets in 2025 (Year End)
$4,029,727
Cash & Equivalents
82%
Investments
14%
Other Assets
2%
Receivables (Non-Related)
2%
Property, Plant, & Equipment (net)
<1%
Prepaid Expenses
<1%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2025 (Year End)
$67,712
Payables & Accruals
52%
Other Liabilities
48%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2024
2025
Change
Cash & Equivalents
$3,311,934
$3,294,169
-1%
Receivables (Non-Related)
$35,220
$72,632
+106%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$10,466
$10,673
+2%
Investments
$547,934
$553,639
+1%
Property, Plant, & Equipment (net)
$29,070
$13,361
-54%
Other Assets
$68,409
$85,253
+25%
Total Assets
$4,003,033
$4,029,727
+1%
Liabilities
2024
2025
Change
Payables & Accruals
$21,565
$35,261
+64%
Grants Payable
-
-
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
$63,649
$32,451
-49%
Total Liabilities
$85,214
$67,712
-21%
Net assets
2024
2025
Change
Restricted Net Assets
$250
$250
+0%
Unrestricted Net Assets
$3,917,569
$3,961,765
+1%
Net assets
2024
2025
Change
Net assets
+$3,917,819
+$3,962,015
+1%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)